7:06 NephU – Genetic Testing In Autosomal Dominant Polycystic Kidney Disease (ADPKD) June 3, 2023 • Kidney Disease Content Hub This webinar snippet features Neera Dahl, MD, PhD, professor of medicine, medical director of nephrology, and director of the Nephrology Clinical Trials Program at Yale School of Medicine,…
1:59 Immunological Mechanism Defense Against COPD Pathogens March 18, 2023 • Allergy / Immunology @DanielEnosi and coauthors demonstrate #immune defense against #COPD #pathogens.
6:40 Successful Treatment-Free Remission in Patients With CML After TKI Discontinuation November 18, 2022 • CML Content Hub @FadiHaddad_MD, of @MDAndersonNews, discusses treatment-free remission in #CML.
1:02 Votobatinib Promising in Phase 1/2 Trial of Mostly Heavily Pretreated CML Patients November 1, 2022 • CML Content Hub @GCC_Cortes, of @GACancerCenter, discusses #votobatinib in #CML.
1:37:47 Small Molecule Inhibitor Reduces Glycogen in Preclinical Mouse Models of Pompe Disease October 13, 2022 • Pompe Disease Content Hub Julie Ullman, PhD, of @MazeInBiotech, discusses #preclinical #results on #MZE001 for #PompeDisease.
5:28 Liquid Biopsy in Lung Cancer Decreases Time to Treatment June 20, 2022 • Oncology Miguel Garcia-Pardo, MD, of @pmcancercentre, discusses #liquidbiopsy in #lungcancer.
18:03 The Impact of Biologic Therapy on IBD Surgical Management March 11, 2022 • Ulcerative Colitis Content Hub @JasonFrischerMD of @CincyChildrens discusses the impact of biologics on IBD surgery.
51:47 Podcast: Data From the True North Study March 9, 2022 • Ulcerative Colitis Content Hub @KakodkarSamir discusses #ozanimod based on the #TRUENORTH study.
2:58 Vitamin D May Reduce Risk of Autoimmune Disorders, Including Rheumatoid Arthritis March 8, 2022 • Rheumatoid Arthritis Content Hub JoAnn Manson, MD, MPH, DrPH, of @BrighamWomens, discusses results of the #VITAL trial.
9:43 Phase 2b Data for Guselkumab in Ulcerative Colitis March 7, 2022 • Ulcerative Colitis Content Hub Axel Dignass, MD, PhD, Goethe University, discusses findings from the phase 2b QUASAR study.
